关于回购公司股份比例达到 3%的进展公告 证券代码：300132 证券简称：青松股份 公告编号：2024-032 福建青松股份有限公司 关于回购公司股份比例达到 3%的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 福建青松股份有限公司（以下简称"公司"）于 2024 年 2 月 19 日召开第五 届董事会第五次会议、第五届监事会第四次会议审议通过了《关于回购公司股份 方案的议案》，同意公司使用自有资金以集中竞价交易方式回购部分公司已发行 的人民币普通股（A 股）股票，用于实施员工持股计划或者股权激励计划。本次 回购股份的资金总额不低于人民币 5,000 万元且不超过人民币 10,000 万元（均 含本数），回购股份的价格不超过人民币 6 元/股（含本数），回购实施期限为 自公司董事会审议通过本次回购股份方案之日起不超过 12 个月。具体内容详见 公司于 2024 年 2 月 19 日在巨潮资讯网（www.cninfo.com.cn）披露的《关于回 购公司股份方案的公告》（公告编号：2024-006）。 2024 年 2 月 29 日，公司首次通过回 ...

关于回购公司股份进展的公告 证券代码：300132 证券简称：青松股份 公告编号：2024-031 福建青松股份有限公司 关于回购公司股份进展的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 福建青松股份有限公司（以下简称"公司"）于 2024 年 2 月 19 日召开第五 届董事会第五次会议、第五届监事会第四次会议审议通过了《关于回购公司股份 方案的议案》，同意公司使用自有资金以集中竞价交易方式回购部分公司已发行 的人民币普通股（A 股）股票，用于实施员工持股计划或者股权激励计划。本次 回购股份的资金总额不低于人民币 5,000 万元且不超过人民币 10,000 万元（均 含本数），回购股份的价格不超过人民币 6 元/股（含本数），回购实施期限为 自公司董事会审议通过本次回购股份方案之日起不超过 12 个月。具体内容详见 公司于 2024 年 2 月 19 日在巨潮资讯网（www.cninfo.com.cn）披露的《关于回 购公司股份方案的公告》（公告编号：2024-006）。 2024 年 2 月 29 日，公司首次通过回购专用账户以集中竞价方式回购 ...

证券代码：300132 证券简称：青松股份 公告编号：2024-030 福建青松股份有限公司 2023 年度股东大会决议公告 2、现场会议召开地点：广东省中山市南头镇东福北路 50 号青松股份中山分 公司会议室 2023 年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： ·本次股东大会无否决或修改议案的情况； ·本次股东大会无涉及变更前次股东大会决议。 一、会议召开情况 1、会议召开时间：2024 年 5 月 30 日（星期四）下午 15:30 （1）现场会议召开时间：2024 年 5 月 30 日（星期四）下午 15:30 （2）网络投票时间：2024 年 5 月 30 日 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为 2024 年 5 月 30 日 9:15—9:25，9:30—11:30 和 13:00—15:00；通过深圳证券交易所互联 网投票系统投票的具体时间为 2024 年 5 月 30 日 9:15—15:00 期间的任意时间。 3、会议召开方式：本次股东大会采用现场表决与网络投票相结合的方式 4、召集 ...

北京市君合(广州)律师事务所 关于 福建青松股份有限公司 2023 年年度股东大会的 法律意见书 二零二四年五月 | 北京总部 | 电话: (86-10) 8519-1300 | 上海分所 | 电话: (86-21) 5298-5488 | 广州分所 | 电话: (86-20) 2805-9088 | | 深圳分所 | 电话: (86-755) 2939-5288 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 传真: (86-10) 8519-1350 | | 传真: (86-21) 5298-5492 | | 传真: (86-20) 2805-9099 | | | 传真: (86-755) 2939-5289 | | 杭州分所 | 电话: (86-571) 2689-8188 | 成都分所 | 电话: (86-28) 6739-8000 | 西安分所 | 电话: (86-29) 8550-9666 | | 青岛分所 | 电话: (86-532) 6869-5000 | | | 传真: (86-571) 2689-8199 | | ...

关于回购公司股份进展的公告 证券代码：300132 证券简称：青松股份 公告编号：2024-029 福建青松股份有限公司 关于回购公司股份进展的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 福建青松股份有限公司（以下简称"公司"）于 2024 年 2 月 19 日召开第五 届董事会第五次会议、第五届监事会第四次会议审议通过了《关于回购公司股份 方案的议案》，同意公司使用自有资金以集中竞价交易方式回购部分公司已发行 的人民币普通股（A 股）股票，用于实施员工持股计划或者股权激励计划。本次 回购股份的资金总额不低于人民币 5,000 万元且不超过人民币 10,000 万元（均 含本数），回购股份的价格不超过人民币 6 元/股（含本数），回购实施期限为 自公司董事会审议通过本次回购股份方案之日起不超过 12 个月。具体内容详见 公司于 2024 年 2 月 19 日在巨潮资讯网（www.cninfo.com.cn）披露的《关于回 购公司股份方案的公告》（公告编号：2024-006）。 截至 2024 年 4 月 30 日收盘，公司通过回购专用账户以集中竞价方 ...

2023年度监事会工作报告 福建青松股份有限公司 2023 年度监事会工作报告 2023 年福建青松股份有限公司（以下简称"公司"或"本公司"）监事会在 全体监事的共同努力下，根据《中华人民共和国公司法》（以下简称《公司法》）、 《中华人民共和国证券法》（以下简称《证券法》）等有关法律法规、规范性文件 的要求及《福建青松股份有限公司章程》（以下简称《公司章程》）和《监事会议 事规则》等相关制度的规定，从切实维护公司利益和广大中小股东权益出发，认 真履行监督职责，依法独立行使职权，对 2023 年度公司各方面情况进行了监督。 监事会对公司主要经营活动、财务状况、重大决策情况及公司董事、高级管理人 员履行职责情况等事项进行了有效监督，保障公司规范运作。现将 2023 年度监 事会工作情况报告如下： 一、2023 年度监事会工作情况 公司监事会设监事 3 名，其中股东代表监事 2 名、职工代表监事 1 名，监事 会的人数及人员构成符合法律法规的要求。报告期内，公司监事会进行了换届选 举，相关程序合法合规。报告期内，公司监事会共召开了 7 次监事会会议，所有 监事均参加了会议，所有议案均获得全票通过，会议的召集、召开 ...

未来三年股东回报规划（2024 年—2026 年） 为完善和健全福建青松股份有限公司（以下简称"公司"）科学、持续、稳 定的分红决策和监督机制，积极回报投资者，根据中国证监会《关于进一步落实 上市公司现金分红有关事项的通知》（证监发〔2012〕37 号）、《上市公司监管指 引第 3 号——上市公司现金分红》（证监会公告〔2023〕61 号）文件精神以及《福 建青松股份有限公司章程》（以下简称《公司章程》）的有关规定，并结合公司实 际发展经营情况，特制定《福建青松股份有限公司未来三年股东回报规划（2024 年—2026 年）》（以下简称"本规划"）。具体内容如下： 一、公司股东回报规划制定的考虑因素 公司制定本规划在综合分析公司经营发展实际情况、股东要求和意愿、社会 资金成本、外部融资环境等因素的基础上，充分考虑公司的战略发展规划及发展 所处阶段、目前及未来的盈利能力和规模、现金流量状况、经营资金需求和银行 信贷及融资环境等情况，建立对投资者持续、稳定、科学的回报规划与机制，保 证利润分配政策的连续性和稳定性，有效兼顾对投资者的合理投资回报和公司的 长远可持续发展。 二、公司股东回报规划制定的基本原则 未来三年 ...

福建青松股份有限公司 独立董事 2023 年度述职报告 独立董事 2023 年度述职报告 各位股东及股东代表： 报告期内，本人未在公司担任除独立董事以外的任何职务，也未在公司主要 股东单位担任任何职务，与公司以及主要股东之间不存在利害关系或其他可能妨 碍进行独立客观判断的关系，不存在其他影响独立性的情况，符合《上市公司独 1 本人作为福建青松股份有限公司（以下简称"公司"或"青松股份"）的独 立董事，在 2023 年度严格按照《中华人民共和国公司法》（以下简称《公司法》）、 《中华人民共和国证券法》（以下简称《证券法》）、《上市公司独立董事管理办法》、 《深圳证券交易所创业板股票上市规则》（以下简称《上市规则》）、《深圳证券交 易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》（以下简称《规 范运作指引》）等相关法律法规、规章、规范性文件以及《公司章程》和《独立 董事工作制度》的相关规定和要求，诚实、勤勉、独立地履行职责，以独立、公 正的精神对公司重大经营事项、法人治理等方面的问题积极献计献策。现就本人 2023 年度履行职责情况报告如下： 一、个人基本情况 董皞：1956 年出生，中国国籍，无境 ...

Financial Performance - The company reported a net profit of negative value for the year 2023, with measures for improving profitability detailed in the management discussion section[2]. - The company's operating revenue for 2023 was ¥1,969,494,717, a decrease of 32.49% compared to ¥2,917,366,476 in 2022[20]. - The net profit attributable to shareholders was -¥68,341,309.97, showing a significant improvement of 90.79% from -¥742,420,713.32 in the previous year[20]. - The net cash flow from operating activities was ¥156,604,754.71, down 54.03% from ¥340,636,749.11 in 2022[20]. - The total assets at the end of 2023 were ¥2,371,146,800.46, a decrease of 26.41% from ¥3,194,595,271.44 at the end of 2022[20]. - The company reported a basic earnings per share of -¥0.1323, improving by 90.79% from -¥1.4372 in 2022[20]. - The weighted average return on equity was -5.08%, an improvement of 37.17% from -42.25% in the previous year[20]. - The company reported a total of ¥14,001,315.12 in non-recurring losses for 2023, compared to gains of ¥16,623,287.54 in 2022[26]. - The company achieved a revenue of CNY 196,131.42 million, a year-on-year decrease of 5.63%, with a gross margin of 11.74%, an increase of 7.35 percentage points[97]. - The company reported a net profit attributable to shareholders of CNY -5,034.26 million, a year-on-year increase of 78.12%[97]. Corporate Governance - The company held 9 board meetings during the reporting period, ensuring compliance with legal and regulatory requirements[180]. - The company established a performance evaluation system linking senior management's performance to their compensation, ensuring transparency in hiring practices[182]. - The company disclosed information accurately and timely, designating a specific website for investors to access relevant information[184]. - The company maintained independence from its controlling shareholder, with no reliance on their assets for operations[187]. - The company has a complete and independent business system for R&D, production, and sales, ensuring no competition with the controlling shareholder[188]. - The company operates an independent financial department, with no shared bank accounts with major shareholders[192]. - The annual general meeting had a participation rate of 20.84% on May 26, 2023, reflecting shareholder engagement[193]. - The first temporary shareholders' meeting in 2023 had a participation rate of 20.62% on August 10, 2023[193]. - The second temporary shareholders' meeting in 2023 had a participation rate of 20.10% on November 21, 2023[193]. - The company is focused on maintaining compliance with independent director regulations following recent board changes[197]. - The company’s strategic committee will need to address the absence of independent directors after Dong Hao's resignation[197]. - The company continues to prioritize governance and leadership stability amid recent changes in its executive team[198]. Business Operations - The company has a total of six wholly-owned subsidiaries, including Nuo Si Bei Cosmetics Co., Ltd. and Guangdong Nuo Si Bei Health Care Products Co., Ltd.[13]. - The company operates primarily in the cosmetics industry, focusing on the design, research, and manufacturing of facial masks, skincare products, and wet wipes[30]. - The subsidiary, Norsbel, accounted for 99.59% of the company's consolidated revenue during the reporting period[31]. - Norsbel focuses on ODM business for cosmetics, providing comprehensive services from design to manufacturing for downstream brand owners[32]. - The company has established long-term partnerships with global suppliers such as BASF and Ashland, enhancing its supply chain efficiency and product quality[86]. - The company has built stable partnerships with numerous well-known domestic and international cosmetic brands[57]. - The company has a diverse product line, including specialized cosmetics, cleaning wipes, and facial masks[48]. - The company has implemented a customer-driven sales model, producing based on confirmed orders[56]. - The company has received recognition as an excellent supplier from various brand clients, enhancing its market reputation[57]. - The company has established a comprehensive quality management system certified by ISO22716, ISO13485, and ISO9001, ensuring product safety and efficacy[92]. Market Trends and Industry Analysis - In 2023, the global beauty market grew to $625.7 billion, with a projected increase to $646.2 billion in 2024, reflecting a year-on-year growth of 3.28%[61]. - The retail sales of cosmetics in China reached ¥414.2 billion in 2023, marking a 5.1% increase compared to the previous year[63]. - The average disposable income per capita in China was ¥39,218 in 2023, with a nominal growth rate of 6.3% and a real growth rate of 6.1%[62]. - The number of licensed cosmetics manufacturers in China reached 7,114 in 2023, with 4,024 located in Guangdong, accounting for approximately 55%[64]. - The market concentration of the top 10 cosmetics brands in China was 16.1% in 2023, a decrease of 2.2 percentage points from 2022, indicating intensified competition[64]. - The online sales channel accounted for 50.75% of the Chinese cosmetics market in 2023, with a market size of ¥404.59 billion, while offline sales accounted for 49.25% with a size of ¥392.61 billion[69]. - The male skincare market in China was valued at ¥11.824 billion in 2023, with a projected annual growth rate of 2.9% over the next five years[68]. - The demand for OEM/ODM services is increasing due to the emergence of new cosmetic brands that lack production capabilities, creating opportunities for competitive contract manufacturers[67]. - The cosmetics industry in China is experiencing a shift towards rational consumption, with consumers prioritizing product quality and service experience[66]. - The regulatory environment for the cosmetics industry is becoming stricter, which may pose short-term challenges but will benefit long-term industry health[70]. Research and Development - The company has a professional R&D team of over 180 people, continuously developing new products to meet diverse client needs[79]. - The company has received multiple awards, including the 2022 Top 10 Chinese Cosmetics Manufacturers and the 2023 Annual Influential ODM Award[58]. - The company has successfully developed over 1,000 new formulas during the reporting period, showcasing its efficiency in technology research and product innovation[89]. - The company has a total of 134 valid patents, including 36 invention patents, 82 utility model patents, and 16 design patents, which support its differentiated product positioning[91]. - The company is actively collaborating with universities and research institutions to enhance its technological innovation capabilities[79]. - The company is exploring the application of active extracts from Tremella fuciformis in facial mask formulations, aiming to expand its product line and market competitiveness[129]. - The company aims to enhance its product offerings in the "natural, efficient, and healthy" category through ongoing R&D efforts[129]. - The company has initiated several R&D projects, including the development of a natural, gentle makeup remover oil, which is currently in the technical design phase[129]. Strategic Initiatives and Future Outlook - The company plans not to distribute cash dividends, issue bonus shares, or increase capital from reserves[3]. - The company aims to enhance its market expansion and product development strategies in the cosmetics sector[31]. - Future outlook includes continued investment in new product development and technology to strengthen market position[31]. - The company is actively pursuing new projects, such as the enzyme production line expansion, with environmental approvals obtained[80]. - The company plans to enhance R&D investment and new product development to strengthen its market position and sustainable profitability[151]. - In 2024, the company aims to focus on cost control and structural adjustments to improve core competitiveness in the cosmetics business[152]. - The company will implement measures to optimize production management, aiming to reduce costs and improve efficiency[155]. - The company intends to strengthen its technological innovation and enhance industry competitiveness through advanced production technologies[159]. - The company is actively exploring diversification in the cosmetics and consumer goods industry through mergers and acquisitions[161]. Risks and Challenges - The company has acknowledged uncertainty regarding its ability to continue as a going concern, as indicated by the negative net profit figures over the past three years[21]. - The company faces risks related to macroeconomic conditions and raw material price fluctuations, which could impact profitability[162]. - The company is at risk of operational performance decline and sustained losses if market conditions do not improve or if it fails to secure new orders[172]. - The cosmetics industry is experiencing increased competition, which may impact the company's sales if it fails to meet customer demands[166]. - The company is focused on enhancing safety and environmental management to reduce operational risks associated with production processes[168].

第三条 公司根据相关法律法规要求及业务经营发展需要，不定期召开专门 会议，专门会议由半数以上独立董事出席或委托出席方可举行。 第四条 专门会议由过半数独立董事共同推举一名独立董事担任召集人，负 责召集和主持；召集人不履职或者不能履职时，两名及以上独立董事可以自行召 集并推举一名代表主持。 独立董事专门会议议事规则 福建青松股份有限公司 独立董事专门会议议事规则 第一条 为进一步完善福建青松股份有限公司（以下简称"公司"）的法人 治理结构、提升规范运作水平，充分发挥独立董事在公司治理中的作用，维护公 司整体利益，保护中小股东及利益相关者的合法权益，根据《中华人民共和国公 司法》《上市公司独立董事管理办法》《上市公司治理准则》《深圳证券交易所 创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业 板上市公司规范运作》等有关法律法规、规章、规范性文件和《福建青松股份有 限公司章程》（以下简称《公司章程》）的规定，并结合公司实际情况，制定本 规则。 第二条 独立董事专门会议（以下简称"专门会议"）是指全部由公司独立 董事参加的会议。独立董事是指不在公司担任除董事外的其他职务，并与公司及 公司主要 ...